Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04485221 · ClinicalTrials.gov registry record
TECPR2 Observational Study
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 5
- Enrollment target
NCT04485221: Completed study, sponsored by University of Florida.
NCT04485221 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04485221 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.
Primary Outcome
This will be monitored through medical history, physical exams, and a neurological exam.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2023-08-17 |
What the finished NCT04485221 record still lists
NCT04485221 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04485221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04485221 about?
NCT04485221 is a clinical study titled "TECPR2 Observational Study". The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.
What is the current status of trial NCT04485221?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-01-20. Estimated completion is 2023-08-17.
Who is sponsoring clinical trial NCT04485221?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI